Works matching IS 2397768X AND DT 2023 AND VI 7 AND IP 1
Results: 147
Single-cell transcriptome sequencing reveals spatial distribution of IL34<sup>+</sup> cancer-associated fibroblasts in hepatocellular carcinoma tumor microenvironment.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00483-9
- By:
- Publication type:
- Article
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00428-2
- By:
- Publication type:
- Article
A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00482-w
- By:
- Publication type:
- Article
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00448-y
- By:
- Publication type:
- Article
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00480-y
- By:
- Publication type:
- Article
SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00486-6
- By:
- Publication type:
- Article
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00484-8
- By:
- Publication type:
- Article
A deep learning model, NAFNet, predicts adverse pathology and recurrence in prostate cancer using MRIs.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00481-x
- By:
- Publication type:
- Article
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00473-x
- By:
- Publication type:
- Article
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00485-7
- By:
- Publication type:
- Article
Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00487-5
- By:
- Publication type:
- Article
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00470-0
- By:
- Publication type:
- Article
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00440-6
- By:
- Publication type:
- Article
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00479-5
- By:
- Publication type:
- Article
Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00478-6
- By:
- Publication type:
- Article
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00476-8
- By:
- Publication type:
- Article
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00429-1
- By:
- Publication type:
- Article
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00449-x
- By:
- Publication type:
- Article
Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00427-3
- By:
- Publication type:
- Article
Reply to: Addressing racial and ethnic disparities in AACR project GENIE.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00426-4
- By:
- Publication type:
- Article
Addressing racial and ethnic disparities in AACR project GENIE.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00425-5
- By:
- Publication type:
- Article
Hyperspectral imaging benchmark based on machine learning for intraoperative brain tumour detection.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00475-9
- By:
- Publication type:
- Article
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00424-6
- By:
- Publication type:
- Article
Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00474-w
- By:
- Publication type:
- Article
Biology-aware mutation-based deep learning for outcome prediction of cancer immunotherapy with immune checkpoint inhibitors.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00468-8
- By:
- Publication type:
- Article
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cells.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00422-8
- By:
- Publication type:
- Article
Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00467-9
- By:
- Publication type:
- Article
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00423-7
- By:
- Publication type:
- Article
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00471-z
- By:
- Publication type:
- Article
AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00472-y
- By:
- Publication type:
- Article
Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00456-y
- By:
- Publication type:
- Article
Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00464-y
- By:
- Publication type:
- Article
In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00454-0
- By:
- Publication type:
- Article
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00466-w
- By:
- Publication type:
- Article
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00434-4
- By:
- Publication type:
- Article
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00458-w
- By:
- Publication type:
- Article
Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00465-x
- By:
- Publication type:
- Article
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00463-z
- By:
- Publication type:
- Article
FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00462-0
- By:
- Publication type:
- Article
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00461-1
- By:
- Publication type:
- Article
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00440-6
- By:
- Publication type:
- Article
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00457-x
- By:
- Publication type:
- Article
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00452-2
- By:
- Publication type:
- Article
Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00460-2
- By:
- Publication type:
- Article
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00442-4
- By:
- Publication type:
- Article
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00449-x
- By:
- Publication type:
- Article
High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00455-z
- By:
- Publication type:
- Article
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00459-9
- By:
- Publication type:
- Article
Colorectal cancer risk stratification on histological slides based on survival curves predicted by deep learning.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00451-3
- By:
- Publication type:
- Article